Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Accured Expenses (2016 - 2026)

Phibro Animal Health has reported Change in Accured Expenses over the past 13 years, most recently at $11.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 55.48% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $23.3 million, down 25.12%, while the annual FY2025 figure was $47.2 million, 286.9% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $11.0 million at Phibro Animal Health, up from -$13.7 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $26.1 million in Q2 2025 and troughed at -$13.7 million in Q3 2025.
  • A 5-year average of $2.6 million and a median of $165500.0 in 2024 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 1357.99% in 2024 and later plummeted 288.42% in 2025.
  • Year by year, Change in Accured Expenses stood at $5.2 million in 2021, then rose by 15.57% to $6.0 million in 2022, then skyrocketed by 36.38% to $8.2 million in 2023, then surged by 202.8% to $24.8 million in 2024, then tumbled by 55.48% to $11.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for PAHC at $11.0 million in Q4 2025, -$13.7 million in Q3 2025, and $26.1 million in Q2 2025.